免疫抑制剂环磷酰胺治疗急性间质性肾炎的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the clinical effect of immunosuppressant Cyclophosphamide in the treatment of acute interstitial nephritis.Methods30 patients with acute interstitial nephritis who were admitted to our hospital from June 2015 to April 2017 were enrolled as the study subjects.According to the different treatment methods,the patients were divided into the control group and the treatment group,with 15 cases in each group.Patients in the control group were given hormones,and patients in the treatment group were given hormones combined with cyclophosphamide immunosuppressant.Improvement of relevant biochemical indicators(including serum uric acid,blood urea nitrogen,serum creatinine,endogenous creatinine clearance rate),the length of hospital stay,the incidence rate of adverse reactions,the total effective rate of treatment were compared between the two groups.ResultsThere were no significant differences in the relevant biochemical indicators of serum uric acid,blood urea nitrogen,serum creatinine,endogenous creatinine clearance rate between the two groups before treatment(P＞0.05).The level of serum uric acid,blood urea nitrogen,serum creatinine in the treatment group after treatment were significantly lower than those in the control group,the level of serum creatinine clearance rate in the treatment group after treatment was significantly higher than the control group,with significant difference (P＜0.05).The length of hospital stay in the treatment group was significantly shorter than that in the control group,with significant difference (P＜0.05).The incidence rate of adverse reactions in the treatment group was 6.7%,which was significantly less than 13.3%in the control group,with significant difference (P＜0.05).Conclusion The application of Cyclophosphamide immunosuppressant in the treatment of patients with acute interstitial nephritis can effectively improve the biochemical indicators of patients,so as to rapidly promote the recovery of renal function in patients,and the efficacy is safe and reliable.

Key words： Immunosuppressant Cyclophosphamide Hormones Acute interstitial nephritis Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIN Bi-hui
	WANG Cai-hong

Cite this article:

JIN Bi-hui,WANG Cai-hong. Clinical effect of immunosuppressant Cyclophosphamide in the treatment of acute interstitial nephritis[J]. 中国当代医药, 2017, 24(31): 83-85.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I31/83

[1]	谌贻璞.急性心力衰竭所致急性肾损伤的肾内科治疗[J].中华临床医师杂志（电子版），2013，7（6）：135-136.
[2]	沈婕，邓蓉蓉，张丽丽，等.慢性肾脏疾病急性加重及其肾功能好转的相关因素分析[J]国际泌尿系统杂志，2014，34（29）：208-212.
[4]	韩冬.糖皮质激素在药物相关急性间质性肾炎治疗中的作用分析[J].中外医疗，2014，33（14）：114-115.
[6]	任海滨，俞香宝，孙彬，等.53例急性间质性肾炎临床病理分析[J].临床肾脏病杂志，2013，13（11）：519-522.
[7]	张红.免疫抑制剂治疗急性间质性肾炎的临床疗效分析[J].中国医师进修杂志，2013，36（4）：49-50.
[8]	周淑华.免疫抑制剂治疗急性间质性肾炎的疗效研究[J].中国卫生标准管理，2015，6（31）：84-85.
[3]	Ehinger KH，Hansson MJ，Sjvall F，et al.Bioequivalence and tolera-bility assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor E[J].Clin Drug Investig，2013，33（1）：25-34．
[5]	Sprunger DB，Olson AL，Huie TJ，et al.Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease[J]. Eur Respir J，2012，39（1）：125-132.
[9]	张铿.免疫抑制剂泼尼松治疗63例急性间质性肾炎患者临床分析[J].中外医疗，2014，33（18）：123-124.
[10]	薛增奇，刘金女，郑设锋，等.探讨免疫抑制剂治疗急性间质性肾炎的临床效果[J].中国地方病防治杂志，2014，29（S1）：198-199.
[11]	韩亚峰，李雯雯.急性间质性肾炎患者的临床治疗浅析[J].世界最新医学信息文摘（电子版），2013，12（3）：169.
[12]	钱卫明，安国辉，郭慧娥，等.中药联合小剂量重组人促红细胞生成素治疗肾性贫血疗效观察[J].中国中西医结合肾病杂志，2016，17（1）：65-66.
[13]	薛增奇，刘金女，郑设锋，等.探讨免疫抑制剂治疗急性间质性肾炎的临床效果[J].中国地方病防治杂志，2014，29（S1）：198-199．
[14]	熊本立，王从敏.肾康注射液联合用药治疗肾小球肾炎合并急性间质性肾炎疗效观察[J].临床合理用药杂志，2013，6（1）：30-31.
[15]	杨梅.免疫抑制剂治疗急性间质性肾炎的临床疗效100例[J].中外医疗，2014，33（18）：121-122．
[16]	刘锦标.急性间质性肾炎的病因特点及临床治疗效果分析[J].中外医学研究，2013，11（36）：125-126．